NPI: 1528113156 · VERO BEACH, FL 32967 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/24/2007
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/24/2007 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,997 | $1.44M |
| 2019 | 21,218 | $3.61M |
| 2020 | 25,243 | $3.97M |
| 2021 | 18,909 | $1.45M |
| 2022 | 11,113 | $1.12M |
| 2023 | 2,523 | $361K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 32,591 | 1,311 | $4.31M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 27,368 | 1,608 | $3.30M |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,571 | 997 | $1.89M |
| A4657 | Syringe, with or without needle, each | 2,801 | 1,359 | $586K |
| J1756 | Injection, iron sucrose, 1 mg | 4,215 | 750 | $554K |
| 85041 | 1,760 | 1,143 | $221K | |
| 85048 | 1,699 | 1,102 | $212K | |
| 83540 | 1,622 | 952 | $191K | |
| 83550 | 1,618 | 950 | $191K | |
| 83970 | 1,391 | 898 | $188K | |
| 82728 | 1,353 | 814 | $185K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 741 | 388 | $86K |
| 82108 | 130 | 98 | $19K | |
| 82746 | 82 | 57 | $12K | |
| 82607 | 61 | 42 | $9K |